Latera RCT - Latera vs. Sham Control for Lateral Nasal Valve Collapse

Completed · Not applicable · Has a placebo group

Conditions studied: Nasal Valve Collapse, Nasal Breathing

In brief

The primary objective of the LATERA RCT is to demonstrate the superiority of the Latera Implant to improve nasal breathing, compared with a Sham Control procedure.

Key facts

Study ID

NCT03400787

Run by

Spirox, Inc.

People needed

137

Starts

2017-11-28

Expected to finish

2020-12-23

Last updated by the study team

2021-02-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Sacramento ENT — Roseville, California, United States
• Breathe Clear Institute — Torrance, California, United States
• ENT of GA — Atlanta, Georgia, United States
• Chicago Nasal and Sinus Center — Chicago, Illinois, United States
• Michiana Sleep and ENT Solutions — South Bend, Indiana, United States
• Albany ENT & Allergy — Albany, New York, United States
• Piedmont ENT — Winston-Salem, North Carolina, United States
• Texas ENT Specialist — Houston, Texas, United States
• ENT Associates of Texas — McKinney, Texas, United States
• Texas Facial Plastics and ENT — San Antonio, Texas, United States
• Ogden Clinic — Ogden, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.